Inhibrx Biosciences, Inc. (NASDAQ:INBX) People

Inhibrx Biosciences, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kristiina Vuori
Other companies: Forian Inc. (Director · Since at least Mar 2, 2021); Bionano Genomics, Inc. (Director · Since at least Jun 6, 2019); Inhibrx Inc (Director · Oct 28, 2021 – May 30, 2024 · Past); Sio Gene Therapies Inc (Director · Oct 5, 2020 – Apr 15, 2021 · Past); WebMD Health Corp (Director · Jul 7, 2014 – Sep 15, 2017 · Past)
Director · Since at least May 24, 2024
Kimberly Manhard
Other companies: Connect Biopharma Holdings Limited (CHIEF DEVELOPMENT OFFICER · Since at least Nov 5, 2026); Inhibrx Inc (Director · Aug 18, 2020 – May 30, 2024 · Past); Heron Therapeutics, Inc. (EVP, Drug Development · Jan 10, 2014 – Apr 13, 2023 · Past); Ardea Biosciences Inc (SVP, Regulatory & Dev Ops · Oct 28, 2011 – Jun 19, 2012 · Past)
Director · Since at least May 24, 2024
Jon Faiz Kayyem
Other companies: Biodesix, Inc. (Director · Since at least Jan 1, 2024); Inhibrx Inc (Director · May 30, 2024 – May 30, 2024 · Past)
Director · Since at least May 24, 2024
Mark P. Lappe
Other companies: Inhibrx Inc (Chief Executive Officer, Director · Aug 18, 2020 – May 30, 2024 · Past); Repros Therapeutics (Director · Sep 29, 2008 – May 20, 2009 · Past)
Founder, Chief Executive Officer · Since at least May 24, 2024
Brendan P Eckelman
Other companies: Inhibrx Inc (Chief Scientific Officer · Aug 18, 2020 – May 28, 2024 · Past)
Chief Scientific Officer · May 24, 2024 – May 29, 2024 · Past
Douglas G. Forsyth
Other companies: Inhibrx Inc (Director · Aug 18, 2020 – May 30, 2024 · Past)
Director · Since at least May 24, 2024
Ashraf AmanullahEVP, Chief Technical Operations Officer · Since at least Nov 5, 2026
Bonne AdamsVP, Operations · Since at least Nov 5, 2026
Brian LoboVP, Formulation Development and Drug Product Manufacturing · Since at least Nov 5, 2026
Carlos BaisEVP, Chief Scientific Officer · Since at least Apr 1, 2025
Dana Ebbets-ReedVP, Quality Assurance · Since at least Nov 5, 2026
Darren BrownVP, Analytical Development and Quality Control · Since at least Nov 5, 2026
David KaoVP, Regulatory Affairs · Since at least Nov 5, 2026
David MatlyPresident · Since at least Apr 1, 2025
Jon Faiz KayyemDirector · Since at least Sep 23, 2026
Josep GarciaEVP, Chief Clinical Development Officer · Since at least Nov 4, 2025
Kate Burke C.P.A.VP, Accounting · Since at least Nov 4, 2026
Kelly DeckEVP, Chief Financial Officer · Since at least Apr 1, 2025
Leah PollemaVP, General Counsel · Since at least Nov 5, 2026
Melissa MastersonVP, Access and Commercialization · Since at least Nov 5, 2026
Robert BoothroydVP, Medical Affairs and Business Development · Since at least Nov 5, 2026
Sean FlanaganVP, Sales · Since at least Nov 5, 2026